Aldeyra Therapeutics, Inc. (ALDX)
5.21
+0.22
(+4.41%)
USD |
NASDAQ |
Feb 24, 16:00
5.21
0.00 (0.00%)
After-Hours: 20:00
Aldeyra Therapeutics Research and Development Expense (Quarterly) : 5.431M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Assertio Holdings, Inc. | 0.379M |
| MediciNova, Inc. | 1.543M |
| Altimmune, Inc. | 14.93M |
| Actinium Pharmaceuticals, Inc. | 4.042M |
| Avanos Medical, Inc. | 6.10M |